Literature DB >> 29296759

A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2.

Shadi Khalil1, Maja Holy1, Stephen Grado1, Robert Fleming2, Ryo Kurita3, Yukio Nakamura3,4, Adam Goldfarb1.   

Abstract

Erythroid progenitors are the largest consumers of iron in the human body. In these cells, a high flux of iron must reach the mitochondrial matrix to form sufficient heme to support hemoglobinization. Canonical erythroid iron trafficking occurs via the first transferrin receptor (TfR1)-mediated endocytosis of diferric-transferrin into recycling endosomes, where ferric iron is released, reduced, and exported to the cytosol via DMT1. However, mice lacking TfR1 or DMT1 demonstrate residual erythropoiesis, suggesting additional pathways for iron use. How iron moves from endosomes to mitochondria is incompletely understood, with both cytosolic chaperoning and "kiss and run" interorganelle transfer implicated. TfR2, in contrast to its paralog TfR1, has established roles in iron sensing, but not iron uptake. Recently, mice with marrow-selective TfR2 deficiency were found to exhibit microcytosis, suggesting TfR2 may also contribute to erythroid hemoglobinization. In this study, we identify alternative trafficking, in which TfR2 mediates lysosomal transferrin delivery. Imaging studies reveal an erythroid lineage-specific organelle arrangement consisting of a focal lysosomal cluster surrounded by a nest of mitochondria, with direct contacts between these 2 organelles. Erythroid TfR2 deficiency yields aberrant mitochondrial morphology, implicating TfR2-dependent transferrin trafficking in mitochondrial maintenance. Human TFR2 shares a lineage- and stage-specific expression pattern with MCOLN1, encoding a lysosomal iron channel, and MFN2, encoding a protein mediating organelle contacts. Functional studies reveal these latter factors to be involved in mitochondrial regulation and erythroid differentiation, with Mfn2 required for mitochondrial-lysosomal contacts. These findings identify a new pathway for erythroid iron trafficking involving TfR2-mediated lysosomal delivery followed by interorganelle transfer to mitochondria.

Entities:  

Year:  2017        PMID: 29296759      PMCID: PMC5728310          DOI: 10.1182/bloodadvances.2016003772

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  64 in total

1.  Iron metabolism in the bone marrow as seen by electron microscopy: a critical review.

Authors:  M C BESSIS; J BRETON-GORIUS
Journal:  Blood       Date:  1962-06       Impact factor: 22.113

2.  Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.

Authors:  H Kawabata; R S Germain; P T Vuong; T Nakamaki; J W Said; H P Koeffler
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation.

Authors:  Paolo Santambrogio; Benedetta Gaia Erba; Alessandro Campanella; Anna Cozzi; Vincenza Causarano; Laura Cremonesi; Anna Gallì; Matteo Giovanni Della Porta; Rosangela Invernizzi; Sonia Levi
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

Review 4.  Iron metabolism: interactions with normal and disordered erythropoiesis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

5.  Iron control of erythroid development by a novel aconitase-associated regulatory pathway.

Authors:  Grant C Bullock; Lorrie L Delehanty; Anne-Laure Talbot; Sara L Gonias; Wing-Hang Tong; Tracey A Rouault; Brian Dewar; Jeffrey M Macdonald; Jason J Chruma; Adam N Goldfarb
Journal:  Blood       Date:  2010-04-20       Impact factor: 22.113

Review 6.  The extrahepatic role of TFR2 in iron homeostasis.

Authors:  Laura Silvestri; Antonella Nai; Alessia Pagani; Clara Camaschella
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

7.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

8.  ATP6V0C knockdown in neuroblastoma cells alters autophagy-lysosome pathway function and metabolism of proteins that accumulate in neurodegenerative disease.

Authors:  Leandra R Mangieri; Burton J Mader; Cailin E Thomas; Charles A Taylor; Austin M Luker; Tonia E Tse; Carrie Huisingh; John J Shacka
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

9.  BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis.

Authors:  Frederik Otzen Bagger; Damir Sasivarevic; Sina Hadi Sohi; Linea Gøricke Laursen; Sachin Pundhir; Casper Kaae Sønderby; Ole Winther; Nicolas Rapin; Bo T Porse
Journal:  Nucleic Acids Res       Date:  2015-10-26       Impact factor: 16.971

10.  MS-1 magA: Revisiting Its Efficacy as a Reporter Gene for MRI.

Authors:  Sofia M Pereira; Steve R Williams; Patricia Murray; Arthur Taylor
Journal:  Mol Imaging       Date:  2016-04-26       Impact factor: 4.488

View more
  17 in total

Review 1.  The flux of iron through ferritin in erythrocyte development.

Authors:  Caroline C Philpott
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

2.  Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells.

Authors:  Moon-Suhn Ryu; Kari A Duck; Caroline C Philpott
Journal:  Blood Cells Mol Dis       Date:  2017-09-28       Impact factor: 3.039

3.  New diagnostic tools for delineating iron status.

Authors:  Yelena Z Ginzburg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 4.  Mitochondria-lysosome contact site dynamics and misregulation in neurodegenerative diseases.

Authors:  Jasmine Cisneros; Tayler B Belton; George C Shum; Catherine G Molakal; Yvette C Wong
Journal:  Trends Neurosci       Date:  2022-04       Impact factor: 13.837

5.  Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites.

Authors:  Stephanie Vrijsen; Céline Vrancx; Mara Del Vecchio; Johannes V Swinnen; Patrizia Agostinis; Joris Winderickx; Peter Vangheluwe; Wim Annaert
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

Review 6.  Mitochondrial Iron in Human Health and Disease.

Authors:  Diane M Ward; Suzanne M Cloonan
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

7.  Transferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms.

Authors:  Mark D Kleven; Shall Jue; Caroline A Enns
Journal:  Biochemistry       Date:  2018-02-12       Impact factor: 3.162

8.  Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.

Authors:  Irene Artuso; Maria Rosa Lidonnici; Sandro Altamura; Giacomo Mandelli; Mariateresa Pettinato; Martina U Muckenthaler; Laura Silvestri; Giuliana Ferrari; Clara Camaschella; Antonella Nai
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

Review 9.  Dysregulated iron metabolism in polycythemia vera: etiology and consequences.

Authors:  Yelena Z Ginzburg; Maria Feola; Eran Zimran; Judit Varkonyi; Tomas Ganz; Ronald Hoffman
Journal:  Leukemia       Date:  2018-07-24       Impact factor: 11.528

10.  Effect of stimulated erythropoiesis on liver SMAD signaling pathway in iron-overloaded and iron-deficient mice.

Authors:  Jana Frýdlová; Daniel W Rogalsky; Jaroslav Truksa; Emanuel Nečas; Martin Vokurka; Jan Krijt
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.